Alpha Diagnostic International, Inc. Anti-human Pituitary adenylate cyclase-activating polypeptide (PACAP) IgG #1, aff pure PACAP11-A

Anti-human Pituitary adenylate cyclase-activating polypeptide (PACAP) IgG #1, aff pure General Information Pituitary adenylate cyclase-activating polypeptide (PACAP) is a bioactive peptide (human 176aa, 175 each in mouse and rat) that was originally isolated from ovine hypothalamus on the basis of its ability to stimulate adenylate cyclase and functions as a n SugApplications Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the SugSecAntibodies http://4adi.com/comm erce/ccc2480-seconda ry-antibodies-rabbit .htm SpeciesReactivity Human SugNegativeControl Non-immune Rabbit IgG Cat# 20009-1 Form Affinity purified IgG SugPositiveControl Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid Antigen 11-aa peptide from Human PACAP (1); Designation (PACAP11-P, control peptide or blocking peptide) conjugated to KLH; epitope location ~ C-terminus SpCrossreactivity The human PACAP11-P control peptide shows 83% sequence identity with mouse and 81% with rat. No significant homology is detected with other species. Antibody cross-reactivity in various species has not been studied For research use only, not for diagnostic or therapeutic use.